ReutersReuters

Dualitybio's Next-Generation Her3 Adc Db-1310 Granted FDA Fast Track Designation

RefinitivMeno di 1 minuto di lettura

Duality Biotherapeutics Inc 9606:

  • DUALITYBIO'S NEXT-GENERATION HER3 ADC DB-1310 GRANTED FDA FAST TRACK DESIGNATION

Accedi o crea un account gratuito per leggere queste notizie